1. Placental DNA methylation levels at CYP2E1 and IRS2 are associated with child outcome in a prospective autism study
- Author
-
Yihui Zhu, Irva Hertz-Picciotto, Keith W. Dunaway, Rebecca J. Schmidt, Ria Marathe, Cheryl K. Walker, Dag H. Yasui, Rochelle L. Coulson, Julia M. Jianu, Charles E. Mordaunt, Janine M. LaSalle, and Sally J Ozonoff
- Subjects
Male ,Autism Spectrum Disorder ,Placenta ,Autism ,Genome-wide association study ,Bioinformatics ,Medical and Health Sciences ,Epigenesis, Genetic ,0302 clinical medicine ,Pregnancy ,Genotype ,2.1 Biological and endogenous factors ,Aetiology ,Child ,Genetics (clinical) ,Pediatric ,Genetics & Heredity ,0303 health sciences ,Cytochrome P-450 CYP2E1 ,General Medicine ,Methylation ,Biological Sciences ,Cadherins ,Mental Health ,Autism spectrum disorder ,Maternal Exposure ,Prenatal Exposure Delayed Effects ,DNA methylation ,embryonic structures ,Female ,General Article ,Disease Susceptibility ,Signal Transduction ,Risk ,Intellectual and Developmental Disabilities (IDD) ,Reproductive Health and Childbirth ,Biology ,behavioral disciplines and activities ,03 medical and health sciences ,Genetic ,Clinical Research ,mental disorders ,medicine ,Genetics ,Humans ,Epigenetics ,Autistic Disorder ,Intellectual and Developmental Disabilities ,Molecular Biology ,030304 developmental biology ,Gene Expression Profiling ,Prevention ,Human Genome ,DNA Methylation ,medicine.disease ,Brain Disorders ,Wnt Proteins ,Differentially methylated regions ,Case-Control Studies ,Insulin Receptor Substrate Proteins ,030217 neurology & neurosurgery ,Biomarkers ,Epigenesis ,Genome-Wide Association Study - Abstract
DNA methylation acts at the interface of genetic and environmental factors relevant for autism spectrum disorder (ASD). Placenta, normally discarded at birth, is a potentially rich source of DNA methylation patterns predictive of ASD in the child. Here, we performed whole methylome analyses of placentas from a prospective study MARBLES (Markers of Autism Risk in Babies—Learning Early Signs) of high-risk pregnancies. A total of 400 differentially methylated regions (DMRs) discriminated placentas stored from children later diagnosed with ASD compared to typically developing controls. These ASD DMRs were significantly enriched at promoters, mapped to 596 genes functionally enriched in neuronal development, and overlapped genetic ASD risk. ASD DMRs at CYP2E1 and IRS2 reached genome-wide significance, replicated by pyrosequencing and correlated with expression differences in brain. Methylation at CYP2E1 associated with both ASD diagnosis and genotype within the DMR. In contrast, methylation at IRS2 was unaffected by within DMR genotype but modified by preconceptional maternal prenatal vitamin use. This study therefore identified two potentially useful early epigenetic markers for ASD in placenta.
- Published
- 2019
- Full Text
- View/download PDF